The objective of these experiements was to increase the pre-operative FNA diagnostic sensibility, as the BRAF mutation does not occur together with the RAS mutation or the RET-PTC rearrangement, indicating different genetic alterations in the pathogenesis of the papillary carcinoma (9). The gene discussed is BRAF; the disease is thyroid gland papillary carcinoma.